Tufts Health Plan Provides Positive Coverage Decision to BioTheranostics | GenomeWeb

NEW YORK (GenomeWeb News) – BioTheranostics today said that it has received a positive coverage decision and in-network provider status from Tufts Health Plan for its CancerTypeID molecular cancer classifier.

Tufts has more than 1 million members.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.